Gary Fowler and Alan Carpino: Targeted Bioscience's AI-Powered Approach in LCM
Apr 19, 2024•26 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
GSD Presents: Frontiers in Disease Management: Targeted Bioscience's AI-Powered Approach in LCM with Alan Carpino April 2, Tuesday Guest: Alan Carpino, CEO, Founder, Targeted BioScience https://www.linkedin.com/in/alan-carpino-820bb4121/ Before founding Targeted Biosciences, Alan was the Director of Commercial Oncology (Clinical Research/Immunotherapy Development) at Fluidigm Corporation. Prior to that, he was the Global Sales and Business Development leader for the Arcturus product line at Thermo Fisher Scientific. He is the co-author of 5 peer-reviewed publications on the use of Laser Capture Microdissection (LCM) in Personalized Medicine. #Tech #AI #HealthcareInnovation #GaryFowler #NoelGonzalez #AlanCarpino #GSD #TargetedBioscience
For the best experience, listen in Metacast app for iOS or Android